Production of the Holmes Documentary
A24 has announced a new feature-length documentary detailing the final days of Elizabeth Holmes before her incarceration. The film, titled You Can See Everything, stems from a partnership between directors Nathan Fielder and Lance Oppenheim. Production occurred in 2023, specifically capturing the period immediately preceding her reporting to prison to begin an 11-year sentence for wire fraud. This project marks another installment in the public documentation of the Theranos saga.
Fielder and Oppenheim gained direct access to Holmes during this window. According to reports from the New York Times, Holmes permitted this filming in an attempt to present her own perspective on the collapse of her blood-testing company. The documentary runtime is three hours. It combines standard interview footage with experimental reenactments to frame the narrative.
The Content and Tone of the Project
Initial teasers for the film show a style consistent with the work of Fielder, known for his earlier series such as The Rehearsal. One scene depicts Holmes engaged in direct, prolonged eye contact with the director. She asks him why she would deceive anyone while asserting there is no logical reason for her to have done so. This segment highlights the confrontational and uncomfortable nature of the interviews.
Beyond these intense exchanges, the film includes footage of Holmes and her current partner. The couple reportedly discusses potential future business ventures, including a plan to launch a new version of their healthcare technology. This unexpected inclusion provides a window into the outlook of the former CEO as she faced the reality of her legal sentence.
Industry Context and Release Details
Theranos became a major subject of scrutiny following revelations that its core technology did not perform as promised. Previous films and series have covered the rise and fall of the startup. This new documentary offers a different approach by focusing on the transition period between the final court verdict and the commencement of the prison term.
Holmes maintains an active presence on the platform X, where she has shared promotional materials for the upcoming release. She describes the posts on her account as containing her own words. The documentary is scheduled for a theatrical release in October. Industry observers expect the film to attract significant interest due to the enduring public curiosity regarding the motivations of the Theranos founder. Whether this project succeeds in shifting the public narrative remains to be seen when the film arrives in cinemas.